These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 21331930)
1. FDG PET and PET/CT for colorectal cancer. Delbeke D; Martin WH Methods Mol Biol; 2011; 727():77-103. PubMed ID: 21331930 [TBL] [Abstract][Full Text] [Related]
2. PET and PET-CT for evaluation of colorectal carcinoma. Delbeke D; Martin WH Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography for evaluation of colorectal carcinoma. Vitola J; Delbeke D Semin Roentgenol; 2002 Apr; 37(2):118-28. PubMed ID: 12134365 [TBL] [Abstract][Full Text] [Related]
4. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer. Laurens ST; Oyen WJ PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer]. Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351 [TBL] [Abstract][Full Text] [Related]
6. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study. Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571 [TBL] [Abstract][Full Text] [Related]
7. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence. Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319 [TBL] [Abstract][Full Text] [Related]
8. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Thrall MM; DeLoia JA; Gallion H; Avril N Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284 [TBL] [Abstract][Full Text] [Related]
9. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Arulampalam T; Costa D; Visvikis D; Boulos P; Taylor I; Ell P Eur J Nucl Med; 2001 Dec; 28(12):1758-65. PubMed ID: 11734912 [TBL] [Abstract][Full Text] [Related]
10. Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data. Smeets P; Ham H; Ceelen W; Boterberg T; Verstraete K; Goethals I Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):327-32. PubMed ID: 20639817 [TBL] [Abstract][Full Text] [Related]
11. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer. Shyn PB; Madan R; Wu C; Erturk SM; Silverman SG AJR Am J Roentgenol; 2010 Feb; 194(2):414-21. PubMed ID: 20093604 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography in colorectal cancer. Flamen P Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236 [TBL] [Abstract][Full Text] [Related]
13. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. Metser U; You J; McSweeney S; Freeman M; Hendler A AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157 [TBL] [Abstract][Full Text] [Related]
14. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma. Chowdhury FU; Bradley KM; Gleeson FV Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259 [TBL] [Abstract][Full Text] [Related]
15. Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment. Nasu K; Abe W; Takai N; Tomonari K; Narahara H Arch Gynecol Obstet; 2011 May; 283(5):1121-6. PubMed ID: 20574659 [TBL] [Abstract][Full Text] [Related]
16. [Importance of FDG-PET/computed tomography in colorectal cancer]. Kleiner S; Weber W Radiologe; 2019 Sep; 59(9):812-819. PubMed ID: 31428810 [TBL] [Abstract][Full Text] [Related]
17. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Pelosi E; Deandreis D Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
19. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. Kim JH; Czernin J; Allen-Auerbach MS; Halpern BS; Fueger BJ; Hecht JR; Ratib O; Phelps ME; Weber WA J Nucl Med; 2005 Apr; 46(4):587-95. PubMed ID: 15809480 [TBL] [Abstract][Full Text] [Related]
20. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Endo K; Oriuchi N; Higuchi T; Iida Y; Hanaoka H; Miyakubo M; Ishikita T; Koyama K Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]